La Rosa, Corinna <br/><br/>
Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant.  [electronic resource] 

 -  The Journal of infectious diseases  Apr 2012 
 - 1294-304 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1537-6613 
<br/><br/><label>Standard No.: </label>10.1093/infdis/jis107  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Adolescent<br/>Adult<br/>Amino Acid Sequence<br/>CD8-Positive T-Lymphocytes--physiology<br/>Cytomegalovirus Infections--prevention & control<br/>Cytomegalovirus Vaccines--administration & dosage<br/>Dose-Response Relationship, Immunologic<br/>Epitopes<br/>Female<br/>Humans<br/>Malaria Vaccines--immunology<br/>Male<br/>Middle Aged<br/>Oligodeoxyribonucleotides--administration & dosage<br/>Recombinant Proteins--immunology<br/>Tetanus Toxoid--administration & dosage<br/>Vaccines, Synthetic<br/>Young Adult